FDA May Seek Blanket Consent Of Industry For Release Of Trade Secret Info
Executive Summary
FDA is seeking alternatives to the current practice of obtaining industry consent on a case-by-case basis in order to share confidential commercial information and trade secrets with foreign governments, FDA Associate Director for International Agreements Merton Smith said at a Dec. 8 public meeting.